OpenAlex
PricingAboutJobs
Log inGet started
Work

Trametinib in the treatment of multiple malignancies harboring MEK1 mutations

HTML

Year: 2019
Type: review
Source: Cancer Treatment Reviews
DOI: 10.1016/j.ctrv.2019.101907
Authors: Tong Lian, Changying Li, Haitao Wang
Institutions: Second Hospital of Tianjin Medical University, Tianjin Medical University
Language: English

Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: trametinib, MEK1 mutations, MEK inhibitors, MAPK signaling, RAS mutations, melanoma, histiocytic neoplasms, colorectal cancer, lung cancer, drug resistance, targeted therapy
SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, Tianjin Medical University
Awards: G2738549467, G3692824515, G4634338292
OpenAlex ID: W2981287953
FWCI: 0.771
Cites: 40
Cited by: 64
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security